Mal sehen, was bei dem Kurs / Kursverlauf alles passieren kann!
Pipeline:
www.verastem.com/products/
Aktueller Kurs: 1,58 +0,15 +10,49 % in USD
|
226 Beiträge ausgeblendet. |
|
Zahlen für Q4/21
- Company Secures up to $150 Million in Non-Dilutive Funding from Oxford Finance LLC;
- Expected Cash Runway Through 2025 to Support Continued Development and Potential Commercial Launches of VS-6766 and Defactinib
- Enrollment Complete in Selection Phase (Part A) of RAMP 201 Evaluating VS-6766 +/- Defactinib for the Treatment of Low-Grade Serous Ovarian Cancer; Expect to Report Results from Part A in 2Q 2022
- Enrollment Complete in Selection Phase (Part A) of RAMP 202 Evaluating VS-6766 +/- Defactinib for the Treatment of KRAS G12V Mutant Non-Small Cell Lung Cancer; Expect to Report Results from Part A in 2H 2022
investor.verastem.com/news-releases/...ter-and-full-year-2021
Durch das Funding mit Oxford wird VSTM wieder interessanter, beobachte ich weiter, Alert bei 1,00$
Zahlen für Q2/22
- expects that it has a cash runway until at least 2025
investor.verastem.com/news-releases/...2022-financial-results
Update
- Results of Part A of RAMP 202 Trial in KRAS G12V-Mutant NSCLC Show VS-6766 ± Defactinib Did Not Meet Criteria to Continue to Expansion Phase
investor.verastem.com/news-releases/...66-clinical-trials-and
Zahlen für Q4/22
investor.verastem.com/news-releases/...ter-and-full-year-2022
Zahlen für Q1/23
investor.verastem.com/news-releases/...2023-financial-results
1/12 RS
investor.verastem.com/news-releases/...es-reverse-stock-split
Vorbörslich -10% auf 11$
85 Mio. $ Offering
Verastem Oncology beabsichtigt, den Nettoerlös aus dem öffentlichen Angebot für:
investor.verastem.com/news-releases/...illion-public-offering
investor.verastem.com/news-releases/...esignation-combination
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
2 | 251 | Verastem - Turnaroundspekulation 2016 | Balu4u | Vassago | 19.01.24 13:08 | |
3 | wieso "wieder" ? Zweistelligkeit war nie gegeben! | bauwi | grips | 01.03.20 17:06 |